Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Sold by XTX Topco Ltd

XTX Topco Ltd trimmed its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 43.9% in the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 9,823 shares of the company’s stock after selling 7,681 shares during the period. XTX Topco Ltd’s holdings in Acadia Healthcare were worth $623,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of ACHC. Blue Trust Inc. increased its holdings in shares of Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company’s stock valued at $36,000 after acquiring an additional 248 shares during the last quarter. GAMMA Investing LLC increased its stake in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after purchasing an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Acadia Healthcare during the second quarter worth $59,000. Covestor Ltd lifted its position in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after buying an additional 1,018 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in shares of Acadia Healthcare in the 3rd quarter valued at about $86,000.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on ACHC. KeyCorp assumed coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating on the stock. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the company from $45.00 to $75.00 in a research note on Thursday. Barclays dropped their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a research note on Friday, November 22nd. Royal Bank of Canada decreased their price objective on Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research note on Tuesday. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $75.44.

Acadia Healthcare Trading Up 1.3 %

Shares of Acadia Healthcare stock opened at $40.34 on Friday. The business has a fifty day simple moving average of $45.69 and a 200-day simple moving average of $61.98. Acadia Healthcare Company, Inc. has a fifty-two week low of $36.50 and a fifty-two week high of $87.77. The firm has a market cap of $3.75 billion, a price-to-earnings ratio of 13.23, a price-to-earnings-growth ratio of 1.82 and a beta of 1.29. The company has a quick ratio of 1.07, a current ratio of 1.07 and a debt-to-equity ratio of 0.60.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. The company had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the company earned $0.91 EPS. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.